Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 188.26 |
| Low | 188.26 |
| Bid | 66.25 |
| Offer | 67.09 |
| Previous close | 188.26 |
| Average volume | -- |
|---|---|
| Shares outstanding | 580.80m |
| Free float | 572.50m |
| P/E (TTM) | 47.86 |
| Market cap | 50.22bn USD |
| EPS (TTM) | 1.81 USD |
Data delayed at least 15 minutes, as of Jun 25 2019 15:30 BST.
More ▼
Press releases
- Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
- Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
- Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
- Edwards Comments on JenaValve Acquisition
- FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
More ▼
